Literature DB >> 3181372

Robust regression in biological assay: application to the evaluation of alternative experimental techniques.

A Marazzi1, C Ruffieux, A Randriamiharisoa.   

Abstract

Robust Huber type regression and testing of linear hypotheses are adapted to statistical analysis of parallel line and slope ratio assays. They are applied in the evaluation of results of several experiments carried out in order to compare and validate alternatives to animal experimentation based on embryo and cell cultures. Computational procedures necessary for the application of robust methods of analysis used the conversational statistical package ROBSYS. Special commands for the analysis of parallel line and slope ratio assays have been added to ROBSYS.

Mesh:

Substances:

Year:  1988        PMID: 3181372     DOI: 10.1007/bf01941184

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


  5 in total

1.  Postimplantation embryo culture for the assessment of the teratogenic potential and potency of compounds.

Authors:  L Cicurel; B P Schmid
Journal:  Experientia       Date:  1988-10-15

2.  Application of the post-implantation rat embryo culture system to in vitro teratogenicity testing.

Authors:  B P Schmid; L Cicurel
Journal:  Food Chem Toxicol       Date:  1986 Jun-Jul       Impact factor: 6.023

3.  Use of aggregating cell cultures for toxicological studies.

Authors:  P Honegger; P Werffeli
Journal:  Experientia       Date:  1988-10-15

4.  Teratogenicity screening in standardized chick embryo culture: effects of dexamethasone and diphenylhydantoin.

Authors:  P Kucera; M B Burnand
Journal:  Experientia       Date:  1988-10-15

5.  Routine teratogenicity test that uses chick embryos in vitro.

Authors:  P Kucera; M B Burnand
Journal:  Teratog Carcinog Mutagen       Date:  1987
  5 in total
  1 in total

1.  Teratogenicity screening in standardized chick embryo culture: effects of dexamethasone and diphenylhydantoin.

Authors:  P Kucera; M B Burnand
Journal:  Experientia       Date:  1988-10-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.